Systems biology approaches to unravel the molecular and genetic architecture of Alzheimer's disease and related tauopathies

Over the years, genetic studies have identified multiple genetic risk variants associated with neurodegenerative disorders and helped reveal new biological pathways and genes of interest. However, genetic risk variants commonly reside in non-coding regions and may regulate distant genes rather than...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Emily Miyoshi, Samuel Morabito, Vivek Swarup
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/b39aa0579d54490483c93a0a58d0f295
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b39aa0579d54490483c93a0a58d0f295
record_format dspace
spelling oai:doaj.org-article:b39aa0579d54490483c93a0a58d0f2952021-11-12T04:26:13ZSystems biology approaches to unravel the molecular and genetic architecture of Alzheimer's disease and related tauopathies1095-953X10.1016/j.nbd.2021.105530https://doaj.org/article/b39aa0579d54490483c93a0a58d0f2952021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S0969996121002795https://doaj.org/toc/1095-953XOver the years, genetic studies have identified multiple genetic risk variants associated with neurodegenerative disorders and helped reveal new biological pathways and genes of interest. However, genetic risk variants commonly reside in non-coding regions and may regulate distant genes rather than the nearest gene, as well as a gene's interaction partners in biological networks. Systems biology and functional genomics approaches provide the framework to unravel the functional significance of genetic risk variants in disease. In this review, we summarize the genetic and transcriptomic studies of Alzheimer's disease and related tauopathies and focus on the advantages of performing systems-level analyses to interrogate the biological pathways underlying neurodegeneration. Finally, we highlight new avenues of multi-omics analysis with single-cell approaches, which provide unparalleled opportunities to systematically explore cellular heterogeneity, and present an example of how to integrate publicly available single-cell datasets. Systems-level analysis has illuminated the function of many disease risk genes, but much work remains to study tauopathies and to understand spatiotemporal gene expression changes of specific cell types.Emily MiyoshiSamuel MorabitoVivek SwarupElsevierarticleTauopathyAlzheimer's diseaseGeneticsTranscriptomicsEpigeneticsNetwork analysisNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571ENNeurobiology of Disease, Vol 160, Iss , Pp 105530- (2021)
institution DOAJ
collection DOAJ
language EN
topic Tauopathy
Alzheimer's disease
Genetics
Transcriptomics
Epigenetics
Network analysis
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
spellingShingle Tauopathy
Alzheimer's disease
Genetics
Transcriptomics
Epigenetics
Network analysis
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Emily Miyoshi
Samuel Morabito
Vivek Swarup
Systems biology approaches to unravel the molecular and genetic architecture of Alzheimer's disease and related tauopathies
description Over the years, genetic studies have identified multiple genetic risk variants associated with neurodegenerative disorders and helped reveal new biological pathways and genes of interest. However, genetic risk variants commonly reside in non-coding regions and may regulate distant genes rather than the nearest gene, as well as a gene's interaction partners in biological networks. Systems biology and functional genomics approaches provide the framework to unravel the functional significance of genetic risk variants in disease. In this review, we summarize the genetic and transcriptomic studies of Alzheimer's disease and related tauopathies and focus on the advantages of performing systems-level analyses to interrogate the biological pathways underlying neurodegeneration. Finally, we highlight new avenues of multi-omics analysis with single-cell approaches, which provide unparalleled opportunities to systematically explore cellular heterogeneity, and present an example of how to integrate publicly available single-cell datasets. Systems-level analysis has illuminated the function of many disease risk genes, but much work remains to study tauopathies and to understand spatiotemporal gene expression changes of specific cell types.
format article
author Emily Miyoshi
Samuel Morabito
Vivek Swarup
author_facet Emily Miyoshi
Samuel Morabito
Vivek Swarup
author_sort Emily Miyoshi
title Systems biology approaches to unravel the molecular and genetic architecture of Alzheimer's disease and related tauopathies
title_short Systems biology approaches to unravel the molecular and genetic architecture of Alzheimer's disease and related tauopathies
title_full Systems biology approaches to unravel the molecular and genetic architecture of Alzheimer's disease and related tauopathies
title_fullStr Systems biology approaches to unravel the molecular and genetic architecture of Alzheimer's disease and related tauopathies
title_full_unstemmed Systems biology approaches to unravel the molecular and genetic architecture of Alzheimer's disease and related tauopathies
title_sort systems biology approaches to unravel the molecular and genetic architecture of alzheimer's disease and related tauopathies
publisher Elsevier
publishDate 2021
url https://doaj.org/article/b39aa0579d54490483c93a0a58d0f295
work_keys_str_mv AT emilymiyoshi systemsbiologyapproachestounravelthemolecularandgeneticarchitectureofalzheimersdiseaseandrelatedtauopathies
AT samuelmorabito systemsbiologyapproachestounravelthemolecularandgeneticarchitectureofalzheimersdiseaseandrelatedtauopathies
AT vivekswarup systemsbiologyapproachestounravelthemolecularandgeneticarchitectureofalzheimersdiseaseandrelatedtauopathies
_version_ 1718431310477787136